Research & Development

Grid Item Thumb
A new report by Boston Healthcare has analysed the limitations of FDA approval with regards to cancer drugs Read more
A recent study in STEM CELLS Translational Medicine could open the door to a new therapy Read more
Several factors have a direct influence on adherence. Read more
Theranos has received much praise along with a healthy dose of skepticism in recent months Read more
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI Read more
In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action Read more
Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market Read more
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting Read more